gantenerumab in early alzheimer’s disease | nejm
Published 9 months ago • 1.8K plays • Length 2:01Download video MP4
Download video MP3
Similar videos
-
1:48
lecanemab in alzheimer’s disease | nejm
-
10:27
alzheimer’s disease — anti-amyloid medications, early detection, and screening | nejm
-
15:32
alzheimer’s disease — managing stages of dementia | nejm
-
0:59
ask the expert — conversations about new alzheimer's medications | nejm
-
2:15
biomarker changes preceding alzheimer’s disease | nejm
-
16:39
nejm interview: dr. gil rabinovici on the fda’s controversial approval of a new treatment for alz...
-
2:42
geoff kerchner, md, phd: gantenerumab as disease-modifying treatment in early alzheimer disease
-
14:37
nejm interview: dr. eric larson on new insights into the dementia epidemic.
-
28:15
alzheimer’s update, part 1
-
1:23
updates in pharmacological treatment of alzheimer’s disease: lecanemab, donanemab and gantenerumab
-
0:28
nejm publishes article on mild cognitive impairment practice at mayo clinic
-
1:27
experimental therapy gantenerumab fails to slow or improve alzheimer's memory loss in clinical
-
1:31
phase ii study of lecanemab in early ad
-
0:28
5 surprising things that can happen in dementia
-
56:06
1/24/2020: brain and cognitive changes in pre-symptomatic alzheimer’s disease: new findings
-
1:58
gantenerumab data presented at ctad- addf statement
-
34:29
management of hyperbilirubinemia in the newborn infant with drs. alex kemper and tom newman
-
0:49
mechanism of amyloid removal in patients with alzheimer disease treated with gantenerumab part 1
-
6:11
early symptoms of alzheimer disease